Douglas Holtzman is CSO at Icosavax, Inc. (ICVX). They have made 2 open-market trades across 1 company since 2022, most recently 2023-07-03.
CIK 0001874371
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICVX | 292,149 | $4.5M |
Shares reported on the most recent Form 4, priced at the 2023-07-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICVX | SELL · 10b5-1 | 2023-07-03 | 2023-07-03 | $8.80 | $269K | +9.5% | +1.8% | -14.6% |
| ICVX | SELL · 10b5-1 | 2023-04-03 | 2023-04-05 | $6.08 | $247K | -14.0% | +6.7% | +44.4% |
| ICVX | SELL · 10b5-1 | 2023-02-13 | 2023-02-15 | $10.33 | $50K | -11.0% | -30.3% | -10.3% |
| ICVX | SELL | 2022-12-15 | 2022-12-16 | $11.14 | $438K | -9.9% | +4.9% | -25.6% |
| ICVX | SELL | 2022-07-29 | 2022-08-02 | $6.66 | $131K | +28.3% | -34.4% | -51.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.